Arterra Bioscience Statistics

Total Valuation

Arterra Bioscience has a market cap or net worth of EUR 12.65 million. The enterprise value is 9.57 million.

Market Cap	12.65M
Enterprise Value	9.57M

Important Dates

The next estimated earnings date is Friday, December 27, 2024.

Earnings Date	Dec 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Arterra Bioscience has 6.66 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	6.66M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	41.07%
Owned by Institutions (%)	n/a
Float	3.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	7.11
EV / Sales	2.63
EV / EBITDA	5.27
EV / EBIT	7.46
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.79, with a Debt / Equity ratio of 0.03.

Current Ratio	8.79
Quick Ratio	7.54
Debt / Equity	0.03
Debt / EBITDA	0.19
Debt / FCF	n/a
Interest Coverage	1,785.49

Financial Efficiency

Return on equity (ROE) is 13.02% and return on invested capital (ROIC) is 7.45%.

Return on Equity (ROE)	13.02%
Return on Assets (ROA)	6.43%
Return on Capital (ROIC)	7.45%
Revenue Per Employee	107,181
Profits Per Employee	39,553
Employee Count	34
Asset Turnover	0.29
Inventory Turnover	1.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.93% in the last 52 weeks. The beta is 1.08, so Arterra Bioscience's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+22.93%
50-Day Moving Average	1.96
200-Day Moving Average	1.98
Relative Strength Index (RSI)	42.92
Average Volume (20 Days)	5,288

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Arterra Bioscience had revenue of EUR 3.64 million and earned 1.34 million in profits.

Revenue	3.64M
Gross Profit	2.03M
Operating Income	1.28M
Pretax Income	1.67M
Net Income	1.34M
EBITDA	1.81M
EBIT	1.28M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 3.43 million in cash and 342,970 in debt, giving a net cash position of 3.08 million or 0.46 per share.

Cash & Cash Equivalents	3.43M
Total Debt	342,970
Net Cash	3.08M
Net Cash Per Share	0.46
Equity (Book Value)	10.60M
Book Value Per Share	n/a
Working Capital	6.83M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.64%, with operating and profit margins of 35.18% and 36.90%.

Gross Margin	55.64%
Operating Margin	35.18%
Pretax Margin	45.82%
Profit Margin	36.90%
EBITDA Margin	49.79%
EBIT Margin	35.18%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 5.21%.

Dividend Per Share	0.10
Dividend Yield	5.21%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	5.21%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Arterra Bioscience has an Altman Z-Score of 5.86.

Altman Z-Score	5.86
Piotroski F-Score	n/a